precision medicine group

Private

Last Round

Buyout/LBO

Nov 20, 2020

Est. Valuation

$2.3B

Total Funding Raised

$500M

Company Overview

Provider of clinical research, development, and commercialization services for the life sciences and pharmaceutical sectors.

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Compare precision medicine group with similar companies based on industry and business-model similarity.

Access detailed peer comparisons, similarity scores, and market data.

Historical fundraising activity

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SEC and related filings with document metadata.

Common questions about precision medicine group's valuation, stock price, and market status.

Headquarters—

Year Founded2012

Last FundingNov 20, 2020

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.